Combined use of oxytocin and Human Chorionic Gonadotropin in intractable pain patients

March 10, 2014

Two hormones credited with reducing pain and need for opioid analgesics when released naturally during pregnancy and childbirth worked similarly when administered simultaneously to patients with intractable pain, research shows.

Following doses of oxytocin (OT) and (HCG), 7 of 9 reported a 30% to 40% reduction in opioid use and baseline pain, in results reported today at the 30th Annual Meeting of the American Academy of Pain Medicine. In addition, the patients reported less intense pain flares, which are sudden exacerbations of pain that occur against a background of persistent pain, and longer periods between flares.

Study author Forest Tennant, MD, said side effects were remarkably few, probably because the hormones are natural, bio-identical compounds. Dr. Tennant is an internist and addictionologist who specializes in research and treatment of intractable pain at the Veract Intractable Pain Clinics he founded in West Covina, Calif.

"The benefit that these patients mostly talk about is somewhat subjective but relates to what patients routinely call a 'feeling of well-being,' 'more alive,' or [increasing] 'will to live," Dr. Tennant said. "They also believe the combination is one they want to continue."

Sometimes referred to as the "bonding ," OT exerts powerful action in the neuroanatomy of intimacy and also acts as a neurotransmitter in the brain. HCG supports the development of the fetus during pregnancy among other roles.

Both hormones surge during and after , and pregnant women have frequently exhibited reduced pain and need for opioids. Dr. Tennant has conducted previous small open-label studies that confirmed a similar effect for both hormones when administered separately in patients who suffer from intractable pain. However, no one had tested the effect of administering both hormones simultaneously until now.

The study, which was cleared by the facility's Institutional Review Board, included 9 patients with intractable pain who were being maintained on 1 or more long- and short-acting opioids. Daily dosages were administered beneath the tongue of HCG ranging from 250 to 500 units and OT in 10 units taken 2 to 4 times. Patients were evaluated for pain relief, side effects, energy, mental function and opioid dose reduction at 2 to 3 months.

One patient stopped the regimen entirely, saying it had no effect. Another patient stopped taking OT because it made her weepy and despondent but continued taking HCG.

All other patients reported a 30% to 40% reduction in opioid use, reduction in baseline pain, flare intensity, or increase in time between flares. Reports of energy, improved mental functions, mood and libido were variable.

Dr. Tennant said though it is premature to justify this type of hormonal therapy in any but patients who are non-responsive to standard treatments, these preliminary results are worth pursuing as an alternative to more symptomatic conventional treatments for intractable pain. Next steps for increasing the clinical relevance of results would be additional open-label trials by multiple observers, he said. He further expects biomarkers of neuroinflammation and glial cell metabolic disturbance to be useful for monitoring treatment success and, to a great extent, influencing treatment selection.

Explore further: High-dose opioids disturb hormones long-term, but mental and physiologic function improves

Related Stories

High-dose opioids disturb hormones long-term, but mental and physiologic function improves

April 11, 2013
Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows. The results, reported today ...

ASA issues top five 'Choosing wisely' recommendations

January 29, 2014
(HealthDay)—The top five anesthesiology-related pain medicine issues that physicians and patients should question have been released by the American Society of Anesthesiologists (ASA) as part of the Choosing Wisely campaign.

Chronic pain and emotional distress often treated with risky medications

November 13, 2013
People suffering from chronic non-cancer pain and severe emotional distress, such as depression, anxiety and substance use, are likely to receive long-term opioid therapy despite a lack of evidence that this treatment helps, ...

Mind over matter: Beating pain and painkillers

February 4, 2014
With nearly one-third of Americans suffering from chronic pain, prescription opioid painkillers have become the leading form of treatment for this debilitating condition. Unfortunately, misuse of prescription opioids can ...

Catastrophizing can predict low back pain, disability

March 3, 2014
(HealthDay)—For patients treated for low back pain, catastrophizing may predict the degree of pain and disability, according to a review published in the Feb. 1 issue of Spine.

Following bariatric surgery, use of opioids increases among chronic opioid users

October 1, 2013
In a group of patients who took chronic opioids for noncancer pain and who underwent bariatric surgery, there was greater chronic use of opioids after surgery compared with before, findings that suggest the need for proactive ...

Recommended for you

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Finding better ways to reduce serious drug side effects

August 14, 2017
Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about ...

Ultrasound-triggered liposomes for on-demand, local anesthesia

August 10, 2017
Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...

Independent pharmacies and online coupons help patients save money on drugs

August 8, 2017
Uninsured patients or those with limited prescription drug coverage can save significant money by buying their drugs at independent pharmacies instead of big box, grocery or chain drug stores and by using discount coupons, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.